Skip links

ACR Convergence, November 10–14, 2022, Philadelphia, PA, US

Our Director Preclinical Development & Project Lead Inflammation Christine Landlinger will attend the ACR Convergence and give a virtual poster presentation on our oxMIF targeting antibody ON104 as a novel treatment approach for Rheumatoid Arthritis.

Home